The role of high-dose therapy with autologous stem cell support in the era of novel agents.
about
First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studiesCombination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study.Immunotherapy using dendritic cells against multiple myeloma: how to improve?Cellular immunotherapy using dendritic cells against multiple myeloma
P2860
The role of high-dose therapy with autologous stem cell support in the era of novel agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of high-dose therapy ...... rt in the era of novel agents.
@en
The role of high-dose therapy ...... rt in the era of novel agents.
@nl
type
label
The role of high-dose therapy ...... rt in the era of novel agents.
@en
The role of high-dose therapy ...... rt in the era of novel agents.
@nl
prefLabel
The role of high-dose therapy ...... rt in the era of novel agents.
@en
The role of high-dose therapy ...... rt in the era of novel agents.
@nl
P1476
The role of high-dose therapy ...... rt in the era of novel agents.
@en
P2093
Jean-Luc Harousseau
Michel Attal
P304
P356
10.1053/J.SEMINHEMATOL.2009.02.006
P577
2009-04-01T00:00:00Z